Rehmannia glutinosa for perimenopausal syndrome in patients with breast cancer: A systematic review and meta-analysis.
- 2025-07
- Meta-Analysis · n = 139
- Saudi medical journal 46(7)
- Dejia Kong
- Feixiang Huang
- Wenhua Liu
- Ma Lin
- Zhumei Sheng
- Junmiao Xu
- PubMed: 40628433
- DOI: 10.15537/smj.2025.46.7.20240572
- High evidence
- Clinical
CHM with Rehmannia glutinosa as the monarch drug significantly improved the Kupperman index (MD= -12.79, p<0.01)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes